Faron Pharmaceuticals Oy (LON:FARN) Stock Crosses Above 50-Day Moving Average – Time to Sell?

Faron Pharmaceuticals Oy (LON:FARN) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 42.59 and traded as high as GBX 44. Faron Pharmaceuticals Oy shares last traded at GBX 41.50, with a volume of 468,191 shares trading hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a debt-to-equity ratio of -133.35, a quick ratio of 1.09 and a current ratio of 0.84. The company has a market cap of £86.00 million, a P/E ratio of -1.92 and a beta of 1.12. The firm has a 50 day moving average price of GBX 42.59 and a 200-day moving average price of GBX 63.93.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.